BR96-Doxorubicin Immunoconjugate
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Biological Response Modifier ->
Immunoconjugate -> BR96-Doxorubicin Immunoconjugate
BR96-Doxorubicin Immunoconjugate Definition
An antibody-drug conjugate composed of the chimeric monoclonal antibody BR96 chemically linked to the cytotoxic drug doxorubicin. The antibody moiety of BMS-182248-1 binds to Lewis Y, a cell surface antigen expressed on many solid tumor types. Thus, the doxorubicin conjugate is targeted specifically to Lewis Y-expressing tumor cells, where it intercalates with DNA, thereby inhibiting DNA replication and repair, RNA synthesis and protein synthesis. (NCI)
BR96-Doxorubicin Immunoconjugate Synonyms
BR96-Doxorubicin Immunoconjugate, BMS-182248-01, BR96-DOX, BR96-DOX immunoconjugate, BR96-Doxorubicin Conjugate, SGN-15, cBR96-Doxorubicin Immunoconjugate
Terms in BR96-Doxorubicin Immunoconjugate category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.